|
1
|
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.75
|
|
2
|
Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure.
|
Eur J Endocrinol
|
2006
|
1.36
|
|
3
|
Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
|
J Clin Oncol
|
2003
|
1.18
|
|
4
|
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
|
J Natl Cancer Inst
|
2017
|
0.75
|
|
5
|
Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.
|
Hum Pathol
|
2011
|
0.75
|